X0306 4 2021-12-13 0 0001434316 FATE THERAPEUTICS INC FATE 0001748177 Valamehr Bahram C/O FATE THERAPEUTICS, INC. 12278 SCRIPPS SUMMIT DRIVE SAN DIEGO CA 92131 0 1 0 0 Chief R&D Officer Common Stock 2021-12-13 4 M 0 25000 2.73 A 181698 D Common Stock 2021-12-13 4 S 0 2100 45.68 D 179598 D Common Stock 2021-12-13 4 S 0 7018 46.72 D 172580 D Common Stock 2021-12-13 4 S 0 6564 47.61 D 166016 D Common Stock 2021-12-13 4 S 0 7718 48.75 D 158298 D Common Stock 2021-12-13 4 S 0 1600 49.27 D 156698 D Stock Option (Right to Buy) 2.73 2021-12-13 4 M 0 25000 0.00 A 2027-01-04 Common Stock 25000 61156 D This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on June 9, 2020. Represents the weighted average sale price of the shares sold from $45.18 to $46.17 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer or a security holder of he Issuer, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes 2 through 6. Represents the weighted average sale price of the shares sold from $46.20 to $47.17 per share. Represents the weighted average sale price of the shares sold from $47.21 to $48.20 per share. Represents the weighted average sale price of the shares sold from $48.21 to $49.20 per share. Represents the weighted average sale price of the shares sold from $49.21 to $49.40 per share. This option is fully vested. /s/ Cindy Tahl, as Attorney-in-Fact 2021-12-14